Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2021 Filed Feb 17, 2021 21:14 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionRestricted stock unit · Derivative | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000012 · wf-form4_161359643259356.xml · derivative · entry 5 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units will vest in three equal annual installments. F4 · derivative.expiration_date: The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:14 UTC |
Bowden ChristopherChief Medical Officer
|
Tax withholdingCommon stock | 2,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000012 · wf-form4_161359643259356.xml · nonDerivative · entry 3 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,062 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:14 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000012 · wf-form4_161359643259356.xml · nonDerivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:12 UTC |
Schenkein David PDirector
|
Exercise / conversionRestricted stock units · Derivative | 8,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000009 · wf-form4_161359634798927.xml · derivative · entry 5 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 8,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units will vest in three equal annual installments. F4 · derivative.expiration_date: The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:12 UTC |
Schenkein David PDirector
|
Tax withholdingCommon stock | 2,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000009 · wf-form4_161359634798927.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,638 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:12 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 8,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000009 · wf-form4_161359634798927.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 16:13 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000010 · wf-form4_161359638023953.xml · derivative · entry 4 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,777 Underlying: Common stock · 889 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 16:13 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionCommon stock | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000010 · wf-form4_161359638023953.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Exercise / conversionRestricted stock units · Derivative | 8,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000013 · wf-form4_161359645668070.xml · derivative · entry 4 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,334 Underlying: Common stock · 8,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Exercise / conversionCommon stock | 8,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000013 · wf-form4_161359645668070.xml · nonDerivative · entry 1 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 21:13 UTC |
FOUSE JACQUALYN ADirector · Chief Executive Officer
|
Exercise / conversionRestricted stock units · Derivative | 11,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000011 · wf-form4_161359639686404.xml · derivative · entry 3 FOUSE JACQUALYN A · CIK 0001405288 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,667 Underlying: Common stock · 11,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 21:13 UTC |
FOUSE JACQUALYN ADirector · Chief Executive Officer
|
Tax withholdingCommon stock | 3,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000011 · wf-form4_161359639686404.xml · nonDerivative · entry 2 FOUSE JACQUALYN A · CIK 0001405288 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,363 Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 21:13 UTC |
FOUSE JACQUALYN ADirector · Chief Executive Officer
|
Exercise / conversionCommon stock | 11,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000011 · wf-form4_161359639686404.xml · nonDerivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 21:14 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000012 · wf-form4_161359643259356.xml · derivative · entry 4 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 21:14 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000012 · wf-form4_161359643259356.xml · nonDerivative · entry 1 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 75 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:22 UTC |
Biller JonathanChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 44,000 | $0.00 Strike: $56.68 | $0.00 |
DisclosureSEC source: 0001439222-21-000004 · wf-form4_161316492476489.xml · derivative · entry 2 Biller Jonathan · CIK 0001744749 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common stock · 44,000 shares Expires 2031-02-10 F3 · derivative.exercise_date: This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:22 UTC |
Biller JonathanChief Financial Officer
|
GrantRestricted stock units · Derivative | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000004 · wf-form4_161316492476489.xml · derivative · entry 1 Biller Jonathan · CIK 0001744749 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common stock · 11,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:22 UTC |
Alenson CarmanPrincipal Accounting Officer
|
GrantStock option (right to buy) · Derivative | 2,961 | $0.00 Strike: $56.68 | $0.00 |
DisclosureSEC source: 0001439222-21-000003 · wf-form4_161316487303183.xml · derivative · entry 2 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,961 Underlying: Common stock · 2,961 shares Expires 2031-02-10 F3 · derivative.exercise_date: This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:22 UTC |
Alenson CarmanPrincipal Accounting Officer
|
GrantRestricted stock units · Derivative | 5,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000003 · wf-form4_161316487303183.xml · derivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,922 Underlying: Common stock · 5,922 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:24 UTC |
Miles DarrinChief Commercial Officer
|
GrantCommon stock · Derivative | 44,000 | $0.00 Strike: $56.68 | $0.00 |
DisclosureSEC source: 0001439222-21-000008 · wf-form4_161316505175434.xml · derivative · entry 2 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common stock · 44,000 shares Expires 2031-02-10 F3 · derivative.exercise_date: This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:24 UTC |
Miles DarrinChief Commercial Officer
|
GrantRestricted stock units · Derivative | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000008 · wf-form4_161316505175434.xml · derivative · entry 1 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common stock · 11,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:23 UTC |
Car BruceChief Scientific Officer
|
GrantStock option (right to buy) · Derivative | 44,000 | $0.00 Strike: $56.68 | $0.00 |
DisclosureSEC source: 0001439222-21-000006 · wf-form4_161316498183368.xml · derivative · entry 2 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common stock · 44,000 shares Expires 2031-02-10 F3 · derivative.exercise_date: This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:23 UTC |
Car BruceChief Scientific Officer
|
GrantRestricted stock units · Derivative | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000006 · wf-form4_161316498183368.xml · derivative · entry 1 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common stock · 11,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:24 UTC |
FOUSE JACQUALYN ADirector · Chief Executive Officer
|
GrantStock option (right to buy) · Derivative | 163,000 | $0.00 Strike: $56.68 | $0.00 |
DisclosureSEC source: 0001439222-21-000007 · wf-form4_161316500956020.xml · derivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,000 Underlying: Common stock · 163,000 shares Expires 2031-02-10 F1 · derivative.exercise_date: This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:22 UTC |
Bowden ChristopherChief Medical Officer
|
GrantStock option (right to buy) · Derivative | 44,000 | $0.00 Strike: $56.68 | $0.00 |
DisclosureSEC source: 0001439222-21-000005 · wf-form4_161316494927551.xml · derivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common stock · 44,000 shares Expires 2031-02-10 F3 · derivative.exercise_date: This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:22 UTC |
Bowden ChristopherChief Medical Officer
|
GrantRestricted stock units · Derivative | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000005 · wf-form4_161316494927551.xml · derivative · entry 1 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common stock · 11,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 04, 2021 Filed Jun 2, 2021 20:09 UTC |
MARAGANORE JOHNDirector
|
GiftCommon stock | 3,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000054 · wf-form4_162266451166925.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,757 F1 · kind: This disposition reflects a bona fide gift of 3,415 shares to charity. Read SEC document |
| January 06, 2021 Filed Apr 15, 2021 20:46 UTC |
Car BruceChief Scientific Officer
|
Exercise / conversionRestricted stock units · Derivative | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000033 · wf-form4_161851957884956.xml · derivative · entry 3 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,874 Underlying: Common stock · 3,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| January 06, 2021 Filed Apr 15, 2021 20:46 UTC |
Car BruceChief Scientific Officer
|
Tax withholdingCommon stock | 1,191 | $44.09 | $52,506.31 |
DisclosureSEC source: 0001439222-21-000033 · wf-form4_161851957884956.xml · nonDerivative · entry 2 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,093 Read SEC document |
| January 06, 2021 Filed Apr 15, 2021 20:46 UTC |
Car BruceChief Scientific Officer
|
Exercise / conversionCommon stock | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000033 · wf-form4_161851957884956.xml · nonDerivative · entry 1 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:21 UTC |
Biller JonathanChief Financial Officer
|
Exercise / conversionRestricted stock units · Derivative | 5,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000071 · wf-form4_160738329299398.xml · derivative · entry 3 Biller Jonathan · CIK 0001744749 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,506 Underlying: Common stock · 5,753 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on December 3, 2019. Beginning on December 3, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on December 3, 2019. Beginning on December 3, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:21 UTC |
Biller JonathanChief Financial Officer
|
Tax withholdingCommon stock | 1,707 | $45.87 | $78,300.09 |
DisclosureSEC source: 0001439222-20-000071 · wf-form4_160738329299398.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,040 Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:21 UTC |
Biller JonathanChief Financial Officer
|
Exercise / conversionCommon stock | 5,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000071 · wf-form4_160738329299398.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 16:38 UTC |
Alenson CarmanPrincipal Accounting Officer
|
GrantRestricted stock units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000063 · wf-form4_160313988956166.xml · derivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022. F2 · derivative.expiration_date: The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 16:24 UTC |
Alenson CarmanPrincipal Accounting Officer
|
SaleCommon stock | 250 | $39.93 | $9,982.50 |
DisclosureSEC source: 0001439222-20-000061 · wf-form4_159925103182387.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · shares: Reflects shares purchased through the Company's employee stock purchase plan. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:12 UTC |
MARAGANORE JOHNDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000050 · wf-form4_159104594054176.xml · derivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F4 · derivative.expiration_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:12 UTC |
MARAGANORE JOHNDirector
|
Exercise / conversionCommon stock | 1,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000050 · wf-form4_159104594054176.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:14 UTC |
Scadden DavidDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000054 · wf-form4_159104604311997.xml · derivative · entry 4 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F4 · derivative.expiration_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:14 UTC |
Scadden DavidDirector
|
Exercise / conversionCommon stock | 1,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000054 · wf-form4_159104604311997.xml · nonDerivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:14 UTC |
Clancy Paul JDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000053 · wf-form4_159104602309461.xml · derivative · entry 4 Clancy Paul J · CIK 0001409601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F4 · derivative.expiration_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:14 UTC |
Clancy Paul JDirector
|
Exercise / conversionCommon stock | 1,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000053 · wf-form4_159104602309461.xml · nonDerivative · entry 1 Clancy Paul J · CIK 0001409601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:13 UTC |
CLARK IAN TDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000051 · wf-form4_159104596967197.xml · derivative · entry 4 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F4 · derivative.expiration_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:13 UTC |
CLARK IAN TDirector
|
Exercise / conversionCommon stock | 1,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000051 · wf-form4_159104596967197.xml · nonDerivative · entry 1 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:13 UTC |
Foster-Cheek Kaye IDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000052 · wf-form4_159104599634402.xml · derivative · entry 4 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F4 · derivative.expiration_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:13 UTC |
Foster-Cheek Kaye IDirector
|
Exercise / conversionCommon stock | 1,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000052 · wf-form4_159104599634402.xml · nonDerivative · entry 1 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:12 UTC |
Ho MaykinDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000049 · wf-form4_159104592041995.xml · derivative · entry 4 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F4 · derivative.expiration_date: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:12 UTC |
Ho MaykinDirector
|
Exercise / conversionCommon stock | 1,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000049 · wf-form4_159104592041995.xml · nonDerivative · entry 1 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:12 UTC |
MARAGANORE JOHNDirector
|
GrantRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000050 · wf-form4_159104594054176.xml · derivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686 Underlying: Common stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F3 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:12 UTC |
MARAGANORE JOHNDirector
|
GrantStock options (right to buy) · Derivative | 8,096 | $0.00 Strike: $53.35 | $0.00 |
DisclosureSEC source: 0001439222-20-000050 · wf-form4_159104594054176.xml · derivative · entry 2 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096 Underlying: Common stock · 8,096 shares Expires 2030-05-28 F2 · derivative.exercise_date: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:14 UTC |
Schenkein David PDirector
|
GrantRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000055 · wf-form4_159104606661360.xml · derivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686 Underlying: Common stock · 1,686 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F3 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.